2023 AACR A new tumor-bearing humanized mouse model to evaluate the efficacy of bispecific T cell engager and monoclonal checkpoint antibodi Published Date March 30, 2023 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen